Arvinas To Present at the 30th Annual Piper Jaffray Healthcare Conference
New Haven, CT, November 20, 2018 –(PRWirePro.com)– Arvinas Inc. (Nasdaq:ARVN), a biotechnology company creating a new class of drugs based on protein degradation, today announced that John G. Houston, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the 30th Annual Piper Jaffray Healthcare Conference on Tuesday, November 27 at 8:00 a.m. ET in New York City. A live audio webcast of the presentation will be available at www.arvinas.com on the Events page. A replay of the webcast will be archived on the Arvinas website for 30 days following the presentation.